Editorial: Decoding novel therapeutic targets, biomarkers, and drug development strategies against neurodegenerative disorders—A multi-omics approach
Authors:
Open Access
- 22 June 2023
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Computational Neuroscience
- Vol. 17, 1227850
Abstract
Editorial: Decoding novel therapeutic targets, biomarkers, and drug development strategies against neurodegenerative disorders—A multi-omics approachKeywords
This publication has 7 references indexed in Scilit:
- Alpha-Synuclein Aggregation in Parkinson's DiseaseFrontiers in Medicine, 2021
- Parkinson's diseaseThe Lancet, 2021
- Alzheimer's diseaseThe Lancet, 2021
- Author Correction: An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s diseaseNature Genetics, 2020
- Applications of machine learning to diagnosis and treatment of neurodegenerative diseasesNature Reviews Neurology, 2020
- Data science in neurodegenerative disease: its capabilities, limitations, and perspectivesCurrent Opinion in Neurology, 2020
- microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancerAgeing Research Reviews, 2019